โ Scribed by Frable, William J.
No coin nor oath required. For personal study only.
B uilding on its commitment to eliminate cancer as a major health problem, the American Cancer Society inaugurates, with this issue of Cancer Cytopathology, the first section of Cancer devoted to a specialty area in the diagnosis, research, and treatment of cancer and related diseases. In 1992, realizing the broadening scope of scientific information related to cancer, the American Cancer Society began to explore the idea of discipline specific sections of the journal for medical specialty areas focused on cancer. The idea behind sections was that they would offer greater opportunity for the dissemination of peer-reviewed scientific information beyond the scope of the American Cancer Society's core interdisciplinary journal, Cancer.
As its mission, Cancer Cytopathology will bring to its readers peerreviewed scientific information focused specifically on cytopathology and related disciplines from both national and international sources for all specialties in oncology. It has been just over 50 years since the publication of the famous monograph by Papanicolaou and Traut, ''The Diagnosis of Uterine Cancer by the Vaginal Smear,'' which ushered in the modern era of cytopathology. 1 With the support of Charles S. Cameron, M.D., Medical Director of the American Cancer Society, and Arthur I. Holleb, M.D., Assistant to the Medical Director, the Papanicolaou smear (Pap smear) was very successfully promoted as a screening test for the detection of precancerous changes and earlystage carcinoma of the uterine cervix. At that time, carcinoma of the cervix was the leading cause of death among women in the United States, and it remains so today in many countries where the Pap smear is either unavailable or in limited use. In the beginning, many were skeptical of the idea that the Pap smear could be used to diagnose cancer before the onset of clinical symptoms or even before the cancer became visible to the eye of the examiner. Perseverance by the American Cancer Society, gynecologists, and some pathologists in the application and interpretation of this screening test largely See referenced original articles on pages 6-9, accounts for the dramatic fall in the death rate from cervical carci-16-21, 29-32, and 33-9 of this issue.
noma during the past 50 years. Today the Pap smear remains the cheapest and the single most effective test for cancer screening,
๐ SIMILAR VOLUMES
This issue of the Journal ofAddictions & Offender Counseling (JAOC) is focused on the general problem of aberrant sexual activity, a problem that clients of our readership commonly experience, sometimes as perpetrator, at other times as victim. The frequency of reports of sexual abuse of children i